OCDX News and Press, Ortho Clinical Diagnostics plc From 02/22/21

Ortho Clinical Diagnostics ([[OCDX]] +3.1%) looks set to end the five-day losing streak after a string of positive sell-side remarks today.The analysts from Citi, Piper Sandler, BofA, Morgan Stanley, and JPMorgan have all initiated the coverage on the stock with buy-equivalent ratings. The pr...

Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify. Economic reports in the week ahead On tap for next week, investors will continue to size up improving economic data and the steady decline in COVID-19 case...

RARITAN, N.J., Feb. 17, 2021 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics Holdings plc (Nasdaq: OCDX) ("Ortho"), one of the world's largest pure-play in vitro diagnostics companies, today announced that S&P Global (“S&P”) upgraded Ortho’s issuer credit rating ...

In this episode of Industry Focus: Wildcard , host Jason Moser and Motley Fool contributor Brian Feroldi take a closer look at Ortho Clinical Diagnostics ' (NASDAQ: OCDX) debut on the public markets to see if this healthcare stock is one worth watching. To catch full epi...

Increases facility by $150 million and extends it to 2026 RARITAN, N.J., Feb. 09, 2021 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics Holdings plc (Nasdaq: OCDX) ("Ortho"), one of the world's largest pure-play in vitro diagnostics companies, today announced that certain of its sub...

Ortho Clinical Diagnostics Announces Closing of Full Over-Allotment Option from Initial Public Offering Canada NewsWire RARITAN, N.J. , Feb. 4, 2021 /CNW/ -- Ortho Clinical Diagnostics Holdings plc (Nasdaq: OCDX) ("Ortho"), the world's largest pure-play in v...